产品名称
抗-CD9 兔抗, affinity isolated antibody
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
antigen 25 kDa
species reactivity
mouse, rat, human
concentration
~1 mg/mL
technique(s)
ELISA: 1:20000
immunofluorescence: 1:100-1:500
immunohistochemistry: 1:50-1:100
western blot: 1:500-1:1000
NCBI accession no.
UniProt accession no.
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Quality Level
Gene Information
human ... CD9(928)
1 of 4
此商品 | SAB5701167 | HPA029577 | HPA066155 |
|---|---|---|---|
| biological source rabbit | biological source rabbit | biological source rabbit | biological source rabbit |
| conjugate unconjugated | conjugate - | conjugate unconjugated | conjugate unconjugated |
| antibody form affinity isolated antibody | antibody form - | antibody form affinity isolated antibody | antibody form affinity isolated antibody |
| Quality Level 100 | Quality Level 100 | Quality Level 100 | Quality Level 100 |
| mol wt antigen 25 kDa | mol wt - | mol wt - | mol wt - |
| species reactivity mouse, rat, human | species reactivity human | species reactivity human | species reactivity human |
Biochem/physiol Actions
CD9（CD9 分子）编码的四次跨膜蛋白参与肿瘤细胞的侵袭、凋亡和对化疗的耐药性。它还参与 EGFR（表皮生长因子受体）和 FGFR（成纤维细胞生长因子受体）信号传导途径。
Disclaimer
除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。
Features and Benefits
您可完全放心的评估我们的抗体。如果抗体在您的应用中没有发挥效果，我们将给予您完全的赔偿或更换抗体。 了解更多。
General description
CD9（CD9分子）编码一种跨膜蛋白四次跨膜蛋白（tetraspanin）。它是四次跨膜蛋白家族成员。它位于人染色体12p13.31。
抗-CD9 抗体检测内源性总 CD9 蛋白水平。
Immunogen
针对人源 CD9 的合成肽产生抗血清。
免疫原范围：101-150
免疫原范围：101-150
Physical form
兔IgG，溶于磷酸盐缓冲盐水（不含Mg2+和Ca2+），pH7.4,150mM NaCl，0.02％叠氮化钠和50％甘油中。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
Yuxuan Fu et al.
Journal of controlled release : official journal of the Controlled Release Society, 335, 584-595 (2021-06-06)
The worldwide spread of COVID-19 highlights the urgent need for an efficient approach to rapidly develop therapeutics and prophylactics against SARS-CoV-2. Extracellular vesicle(EVs) are recognized and endocytosed by tissue cells via specific interactions between surface membrane proteins, where after they
Yuxuan Fu et al.
MedComm, 4(5), e384-e384 (2023-09-27)
Extracellular vesicles (EVs), including exosomes and microvesicles (MVs), are released by most cell types into the extracellular space and represent the pathophysiological condition of their source cells. Recent studies demonstrate that EVs derived from infected cells and tumors contribute to
Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells
Lee JK, et al.
Genome Biology (2003)
Zeyan Liang et al.
Neural regeneration research, 19(10), 2259-2269 (2024-03-15)
JOURNAL/nrgr/04.03/01300535-202410000-00027/figure1/v/2024-02-06T055622Z/r/image-tiff Spinal cord injury is a disabling condition with limited treatment options. Multiple studies have provided evidence suggesting that small extracellular vesicles (SEVs) secreted by bone marrow mesenchymal stem cells (MSCs) help mediate the beneficial effects conferred by MSC transplantation
Yuxuan Fu et al.
PLoS pathogens, 19(1), e1011090-e1011090 (2023-01-13)
Specific virus-receptor interactions are important determinants in viral host range, tropism and pathogenesis, influencing the location and initiation of primary infection as well as viral spread to other target organs/tissues in the postviremic phase. Coxsackieviruses of Group B (CVB) and
Active Filters
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持